Differences in immune-related semaphorin levels in the CSF and serum of newly diagnosed, treatment-naive patients with relapsing-remitting multiple sclerosis: a case-control study.
- DOI
- 10.3389/fneur.2026.1851383
- Published
- 2026
- Container
- Frontiers in neurology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fneur.2026.1851383,
title = {Differences in immune-related semaphorin levels in the CSF and serum of newly diagnosed, treatment-naive patients with relapsing-remitting multiple sclerosis: a case-control study.},
author = {Sarıdaş F and Aydın B and Özpar R and Koç ER and Hakyemez B and Alkan T and Turan ÖF},
year = {2026},
journal = {Frontiers in neurology},
doi = {10.3389/fneur.2026.1851383},
url = {https://doi.org/10.3389/fneur.2026.1851383}
}RIS
TY - JOUR TI - Differences in immune-related semaphorin levels in the CSF and serum of newly diagnosed, treatment-naive patients with relapsing-remitting multiple sclerosis: a case-control study. AU - Sarıdaş F AU - Aydın B AU - Özpar R AU - Koç ER AU - Hakyemez B AU - Alkan T AU - Turan ÖF PY - 2026 JO - Frontiers in neurology DO - 10.3389/fneur.2026.1851383 UR - https://doi.org/10.3389/fneur.2026.1851383 ER -
APA
F, S., B, A., R, Ö., ER, K., B, H., T, A., & ÖF, T. (2026). Differences in immune-related semaphorin levels in the CSF and serum of newly diagnosed, treatment-naive patients with relapsing-remitting multiple sclerosis: a case-control study.. Frontiers in neurology. https://doi.org/10.3389/fneur.2026.1851383
Source records
- pubmed · retrieved 2026-09-25T05:52:12.279Z